TAG:
informatics
New Lab Company Is Launched By Geisinger Health System
By Robert Michel | From the Volume XVI No. 12 – August 31, 2009 Issue
WITH A SIMPLE ANNOUNCEMENT last month, Geisinger Health System of Danville, Pennsylvania, launched a new laboratory outreach company, called Proven Diagnostics. From a facility located in Bethlehem, Pennsylvania, Proven Diagnostics intends to compete for lab testing…
Kaiser in Colorado Uses Lab Test Data to Improve Cardiac Care
By Robert Michel | From the Volume XVI No. 6 – April 27, 2009 Issue
CEO SUMMARY: Proud of a 73% reduction in mortality among patients with coronary artery disease (CAD) at Kaiser Permanente Colorado, clinical care teams there demonstrate how integrated care and more effective use of laboratory test data can lead to remarkable improvements in pati…
Diagnostic Errors Get Attention As Next Patient Safety Goal
By Robert Michel | From the Volume XVI No. 5 – April 6, 2009 Issue
PHYSICIAN LEADERS IN PATIENT SAFETY are turning up the heat on doctors to reduce the incidence of diagnostic errors. This is a topic few dared to openly discuss until recently. It is directly linked to Medicare and private payer efforts to crack down on medical errors. This development has profound …
Inverness Medical, ACON, LabInfotech, Kaiser Permenante
By Robert Michel | From the Volume XVI No. 5 – April 6, 2009 Issue
INVERNESS ACQUIRES TEST BUSINESS FROM ACON WITH A STRATEGY OF BECOMING DOMINANT in the consumer testing market and point-of- care (POC) testing sector, Inverness Medical Innovations, Inc., of Waltham, Massachusetts, has actively acquired companies a…
Molecular Advances Soon To Reshape Anatomic Path
By Robert Michel | From the Volume XVI No. 3 – February 23, 2009 Issue
CEO SUMMARY: Early this month, the second annual Molecular Summit assembled molecular first movers and early adopters to discuss their efforts to integrate molecular imaging and molecular diagnostics in patient care. One clear message emerged from two days of presentations and di…
Denver’s UniPath Sells Its Histo Labs to APP
CEO SUMMARY: UniPath ended a long search for a business partner with ample capital and resources to help it continue its aggressive rates of growth in specimen volume, market share, and revenue. UniPath announced the sale of its technical laboratories to American Pathology Partne…
Multi-Modality Diagnosis Heading for Lab Medicine
By Robert Michel | From the Volume XV No. 16 – December 01, 2008 Issue
CEO Summary: At the upcoming Molecular Summit in Philadelphia on February 10-11, 2009, pathologists, molecular imaging experts, and informaticians will share the latest developments on the integration of in vivo (imaging) and in vitro (pathology) diagnost…
Siemens, BioImagene, Clarient University of Pennsylvania, Mayo Clinic
By Robert Michel | From the Volume XV No. 14 – October 20, 2008 Issue
SIEMENS INVESTS IN DIGITAL PATHOLOGY, BUYS STAKE IN BIOIMAGENE IMAGING AND RADIOLOGY GIANT SIEMENS just made an interesting investment in digital pathology systems. On October 16, Siemens Venture Capital (SVC) revealed that it had purchased…
Health Record Databanks Are Different Than RHIOs
By Robert Michel | From the Volume XV No. 12 – September 8, 2008 Issue
CEO SUMMARY: Forget CHINs from the 1990s and RHIOs from this decade. The future of regional health data repositories may turn out to be a patient-controlled model, often called a “Health Record Bank” (HRB). Here is the lab industry’s first look at this nascent movement. HRBs are und…
Is Digital Path Imaging Ready for Prime Time?
By Robert Michel | From the Volume XV No. 9 – July 7, 2008 Issue
CEO SUMMARY: Digital pathology imaging systems are finding uses in all phases of drug discovery (discovery, pre-clinical, clinical trials), as well as education, research, and clinical. One hurdle to widespread adoption of fully digitized, whole-slide pathology imaging systems is FDA clea…
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized